[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2633 followers Created: 2025-07-17 05:32:24 UTC $PARIS:COX, PARIS:FR Nicox and Kowa ink deal worth €191.5 million granting exclusive rights to Glaucoma Treatment NCX XXX in U.S. and unlicensed territories. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$pariscox](/topic/$pariscox) [Post Link](https://x.com/OzmosiHealth/status/1945718204485284319)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2633 followers
Created: 2025-07-17 05:32:24 UTC
$PARIS:COX, PARIS:FR Nicox and Kowa ink deal worth €191.5 million granting exclusive rights to Glaucoma Treatment NCX XXX in U.S. and unlicensed territories.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1945718204485284319